Clinical pharmacist, passionnate about contributing to better use of medications in clinical practice, and specifically in older adults.
Brussels, Belgium
Joined November 2021
- Tweets147
- Following255
- Followers284
- Likes366
Anne Spinewine retweeted
🌟 Meet the first 2 inspiring individuals who successfully reduced or quit #sleepingpills and the contribution of #health professionals in their journey! Discover these real-life based stories. #BenzoAwarenessDay (besafe-horizon.eu)
Anne Spinewine retweeted
We are excited to introduce our first publication today: the Risks of Taking Sleeping Pills infographic, part of the BESAFE HORIZON EU project! Join us in raising awareness about the #benzodiazepines risks and discover the impact of healthy habits in our sleep #BenzoAwarenessDay
Looking forward to meeting great people at #ICOD2 #deprescription. Let's register now!
Anne Spinewine retweeted
Scoping review shows #deprescribing recommendations are increasingly being incorporated into guidelines! 📈
However, detailed guidance on "how" to #deprescribe is still lacking: buff.ly/3Kjfrjz
More resources on "how" to #deprescribe here:
buff.ly/48I6Ph9
💊What do clinical practice guidelines say about deprescribing?
qualitysafety.bmj.com/conten…
⭐️ Superstar team led by @Reeve_Research, with @CentMedUseSafet research students, @wadddee @BarbFarrell8T6 @FrankMoriarty @Daniellep89 @DanijelaGnjidic @OptimisingRxUse & @NJAilabouni!
Deprescribing networks worldwide are so inspiring to me and many others. Thanks @DrEmilyMcD for leading this report. Looking forward to future moments to network including #icod2!
Connecting with #deprescribing networks means more thought sharing, stronger initiatives & a greater impact.
We're so proud of our partnerships with @DeprescribeUS @DeprescribeAU @NDeprescribing!
Read the full article to know more about each network:
tinyurl.com/3ddnrvkh
Great opportunity to work on #deprescribing with @FrankMoriarty
Interested in pharmacoepi, deprescribing and big data?
We're hiring 4 researchers for a research programme @RCSIPharmBioMol funded by @wellcometrust to develop methods and generate evidence on the effects of deprescribing.
Links in the next tweet, D/L 22nd Apr, RTs appreciated!
I was so pleased to share at #SFPC2024 how #implementation science could move #clinicalpharmacy forward. Great conference and discussions!
2 weeks left to finalise abstracts on our latest #deprescribing research for #ICOD2024. We're almost ready. And you?
⏱️Tik Tok⏱️16 days before the call for abstracts closes! Would you like to share your research or clinical experience? Do you have ideas for a workshop? Submit them before February 29! #ICOD2024
Anne Spinewine retweeted
🩺 How to omptimize the use of linezolid in clinical practice ? Read our last paper @ASpinewine :
Towards a better detection of patients at-risk of linezolid toxicity in clinical practice: a prospective study in three Belgian hospital centers frontiersin.org/articles/10.…
ICOD2 is on its way! It's time to prepare our abstracts on #deprescribing to share them with this faulous international audience- Original research, clinical pearls and workshops.
📣 Attention Deprescribers! 📣
The call for abstracts for the ICOD2 is open! We are welcoming original research, clinical pearls and workshop proposals for this issue.
👉🏻 Please connect on icod2.sciencesconf.org for more information, and submit before February 29th, 2024! 🥳
Anne Spinewine retweeted
📣 Attention Deprescribers! 📣
The call for abstracts for the ICOD2 is open! We are welcoming original research, clinical pearls and workshop proposals for this issue.
👉🏻 Please connect on icod2.sciencesconf.org for more information, and submit before February 29th, 2024! 🥳
Anne Spinewine retweeted
Come and work with me! Research Fellow in Deprescribing
@DeprescribeAU @CentMedUseSafet @MonashPharm
careers.pageuppeople.com/513…
Anne Spinewine retweeted
Closing date tomorrow for three post-doc position on the #MIDAS trial, evaluating social prescribing and pharmacist review in general practice.
@RCSIPharmBioMol @Pharmacy_UCC @TCDPharmacy @IrishPharmacy @PharmacistsIER
This Post is from an account that no longer exists. Learn more
Anne Spinewine retweeted
Understanding how quality improvement interventions work is difficult without full intervention description
Pleased to share our work applying behavioural lens to surface active ingredients & causal assumptions of existing large-scale interventions (1/3) journals.sagepub.com/doi/10.…
Anne Spinewine retweeted
Patient and public involvement in pragmatic trials:
The authors searched for pragmatic trials in MEDLINE and invited corresponding authors to participate in an online survey ➡️ cmajopen.ca/lookup/doi/10.97…
ALT Three female doctors looking at a laptop screen.
📢Today in @TheLancet: Beyond recos on the use of #benzodiazepines, recos on when and how to #deprescribe are needed. Beyond research on new drugs, we need research on approaches to deimplement practices that are widely used but jeopardize patients’ safety lnkd.in/eKdz6c9R
📢 Our correspondence in @TheLancet emphasizes deprescribing for safer practices of #insomnia treatment in #olderadults. Check out the key points here🌐 linkedin.com/pulse/eu-funded… @BESAFE_HORIZON #Research #Patientsafety
Anne Spinewine retweeted
We’re hiring x2! Research Coordinator (ohri.ca/careers/Details.aspx…) to coordinate equity-focused BeSci & ImpSci qual studies & sys reviews in chronic disease, + Research Assistant (ohri.ca/careers/Details.aspx…) to support sys reviews & ethics apps in range of BeSci & ImplSci studies.
Anne Spinewine retweeted
The D-PRESCRIBE trial crosses the Atlantic! How will it be received? This adaptation for the Belgian community setting will generate worldwide learnings for #deprescribing leaders interested in implementation sciences. @cara_tannenbaum
Let's not start developing #deprescribing interventions from scratch. @CatherinePetein has adapted the Canadian D-PRESCRIBE intervention to the Belgian context. Can't wait to know the results from the ongoing feasibility study! #eugms2023
Anne Spinewine retweeted
@BESAFE_HORIZON will participate in the #patient #involvement webinar. We can't wait to share patients voice on meaningful involvement for quality and safety research. Save the date! safestsurgery.eu/news/regist…
Let's not start developing #deprescribing interventions from scratch. @CatherinePetein has adapted the Canadian D-PRESCRIBE intervention to the Belgian context. Can't wait to know the results from the ongoing feasibility study! #eugms2023